A ttributed to Albert Einstein, the saying, "Everything should be made as simple as possible, but not simpler," embodies a concept that certainly applies to our understanding and interpretation of fractional flow reserve (FFR) across the most clinically important stenosis interventionalists encounter, the left main (LM) stenosis. Remarkable technical advances supported by multicenter, long-term outcome studies have validated FFR for daily use in the cardiac catheterization laboratory. FFR, the ratio of coronary pressure beyond a stenosis to the aortic pressure (representing the normal coronary pressure in the absence of a stenosis), measured during maximal hyperemia (ie, minimal myocardial bed resistance) identifies the ischemic potential of the lesion. In practice, FFR guidance for multivessel percutaneous coronary intervention compared with angiographic guidance alone produces better clinical and economic outcomes. 1,2
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Such as occurs with all diagnostic testing in medicine, the correct interpretation of results depends not only on the quality of the testing method, but also on the clinical circumstances under which the test is conducted. The same principle applies to FFR. Measuring FFR across an LM stenosis without disease in its branches is relatively simple. The pressure wire is advanced beyond the narrowing into the unobstructed branches, either the left anterior descending (LAD) or the circumflex (CFX) artery, and hyperemic coronary and aortic pressure ratios are computed as FFR. A few caveats for obtaining an accurate FFR include correct zeroing and equilibration of pressures, ensuring the guide catheter is not obstructing LM flow, and administering an adequate dose of adenosine (Table) . For the slightly more complicated scenario of a distal LM bifurcation lesion, one should measure FFR in both branches. In either case, LM lesions treated medically for FFR >0.80 are associated with excellent 5-year major adverse cardiac event rates. 3 Now for the not-so simple part, interpreting LM FFR in the more complicated angiographic scenario where there is downstream stenoses (ie, LM/LAD), the combination of LM/LAD stenoses requires understanding FFR and the interplay of 2 new conditions: (1) lesions acting in series and (2) potential reduction of the maximal LM blood flow (and myocardial bed size), as a function of the degree of obstruction of the downstream lesion.
For serial lesions, an accurate FFR requires that maximal hyperemia be achieved across a target lesion. Each of the serial lesions blunts the hyperemia of the other, and thus simple pressure ratios (without using a distal coronary balloon occlusion pressure) 4,5 cannot produce accurate individual FFR values. In clinical practice, the summed FFR across both lesions (LM+LAD=FFR epicardial ) determines the need to treat; and a pressure pullback recording tells us which lesion to treat. The lesion with the largest pressure (ΔP, not FFR) is treated first, and then FFR across the remaining lesion determines the next treatment decision. Such a method can be used to assess serial LM with LAD disease, but this approach engenders a downside: accepting stenting of the unprotected LM, if after treating the LAD the LM FFR becomes abnormal.
When Does a Left Anterior Descending Stenosis Alter Flow Across a Left Main Segment? Interpreting Left Main Fractional Flow Reserve With Downstream Obstruction
Morton J. Kern, MD, FSCAI For the role of the myocardial bed, fundamental theory states that myocardial blood flow is related to ventricular mass (ie, the size of the myocardial bed). The LM myocardial bed is large, comprising the LAD and CFX beds. However, an LAD lesion downstream from the LM narrowing makes assessment problematic with the unknown amount of bed flow beyond an LAD obstruction. Convincing demonstrations of the influence of myocardial bed size on FFR have been provided by Iqbal et al 6 and Sachdeva and Uretsky, 7 showing that LAD FFR can increase after right coronary artery recanalization of previously collaterally supplied right coronary artery territory (Figure) .
Editorial
Because coronary artery disease is a diffuse process, there is always some disease in branches beyond a narrowed LM. Although this situation seems complex enough to invalidate FFR for the LM/LAD anatomy, in this issue of Circulation: Cardiovascular Interventions, Yong et al 9 demonstrate that only a severe and proximal LAD will artificially influence the LM FFR. Extending the prior research of Daniels et al 10 from a bench model to experimental animals, Yong et al 9 answered the question, "How severe does an LAD stenosis need to be to affect the FFR across a LM stenosis?" Using pressure sensor wires in the LAD and CFX, balloon catheters were used to create variable stenoses in the LM and LAD. After establishing an LM stenosis, followed by increasing LAD stenoses, the investigators found that the difference between the FFR in the LM with no LAD stenosis (FFR true ) and the LM FFR with an LAD stenosis (FFR apparent ) correlated directly with increasing LAD stenosis severity. For the whole cohort of measurements, the mean difference (FFR true −FFR apparent ) was 0.035 U and was only >0.05 U when the FFR epicardial was <0.50. Worth noting is that the proximal compared with mid-LAD stenosis had greater effect on FFR apparent , and there were no cases of FFR true <0.75 when the FFR apparent >0.80 appeared with FFR epicardial was >0.5, findings that mean only a severe and proximal LAD stenosis significantly influenced the LM FFR true .
Yong et al 9 are to be congratulated for translating the clinical problem to the research bench 10 and back to the animal model, providing some direction for the clinician in the human laboratory. We should keep several limitations of this study in mind. The measurements of reversing the bed stenosis, that is producing a CFX stenosis and measuring beyond the LM in the LAD, were not performed. There is no reason to think that in the same model, the same results could not be obtained from the reverse situation with LM/CFX disease. Of relevance to this issue is that unlike in sheep, patients usually have a larger LAD than CFX myocardial bed. Another scenario that remains to be investigated is the LM FFR with both LAD and CFX (LM/LAD/CFX) stenoses. This problem moves the clinical decision into consideration of the patient with multivessel, complex coronary artery disease where coronary bypass graft surgery may be a more practical and better therapeutic option.
Another minor methodologic concern was the difficulty in creating acutely a stable stenosis in compliant sheep arteries and the potential of rapidly forming collaterals, both of which may explain some of the variance of the FFR apparent >FFR true . Differences of >0.025 U can be seen at all FFR epicardial values, with the largest difference occurring at FFR epicardial <0.60. FFR apparent <FFR true by >0.025 U, however, is rare. It was also gratifying to know that FFR apparent >0.80 was unaffected by FFR epicardial when >0.5, a valuable observation that will need validation before widespread clinical application. For the moment and based on these results, the principal finding that an FFR epicardial >0.5 has a limited effect on our ability to correctly interpret FFR true for the LM/LAD lesion should be accepted.
However, there will be some uncertainty about the LM/ LAD complex when the FFR epicardial is <0.5. What should we do in lieu of definitive clinical, human data on the LM/LAD scenario? Although personally not a strong advocate of intravascular ultrasound for LM lesion assessment, we should consider the work of Puri et al 11 recommending the use of FFR for the assessment of the simple, isolated ostial or midshaft LM coronary stenoses. In those patients with the not-so-simple lesions, for example, distal LM bifurcation or LM/LAD±CFX coronary arterial disease, the liberal use of intravascular ultrasound is suggested. Because this recommendation appeared before the current study of Yong et al, 9 a cautionary note regarding intravascular ultrasound is in order. Although a minimal luminal area of >6 mm 2 is an oft-quoted threshold, 12 it is but a conservative approximation of true physiology, best indicating a lack of functional significance rather than an minimal luminal area <6 mm 2 being an indication to treat.
Although incompletely studied at this time in patients having the scenario tested by Yong et al, 9 it is highly likely that the FFR will be proved to be as useful and efficacious for the LM/ LAD lesion assessment as it has in other simple and complex lesions subsets. For patient care, FFR is just simple enough, providing objective information for excellent clinical decisions in the catheterization laboratory.
